End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 NZD | -3.45% | -6.67% | -20.00% |
May. 01 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
Apr. 24 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 177M | |
+30.38% | 684B | |
+29.42% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.23% | 240B | |
+9.21% | 208B | |
-7.48% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- AFT Stock
- News AFT Pharmaceuticals Limited
- Transcript : AFT Pharmaceuticals Limited, 2020 Earnings Call, May 20, 2020